je.st
news
Tag: progenics
Premarket Biotech Digest: Cancer Facts, Progenics' Relistor, Roche On Biotech Bubble
2015-09-16 15:08:07| Biotech - Topix.net
There are going to be about 1,658,370 new cancer cases in 2015. This figure excludes noninvasive, in situ cancers, and others that do not need to be reported.
Tags: cancer
facts
digest
bubble
Revisiting The Investment Case On Progenics Pharmaceuticals
2015-06-14 14:46:06| Biotech - Topix.net
The stock of small biotech Progenics Pharmaceuticals has been on the move since I last profiled the company over a month ago. The company recently got approved by the European Commission to expand distribution of its lead product and this should boost sales in the years ahead.
Tags: case
investment
pharmaceuticals
revisiting
Progenics Pharmaceuticals Sets Fourth Quarter and Year End 2014 Financial Results Call for March 16
2015-03-09 17:47:47| Biotech - Topix.net
Progenics Pharmaceuticals, Inc., , an oncology company focused on developing innovative ways to target and treat prostate cancer, announced today that it will host a conference call and webcast to review fourth quarter and year end 2014 financial results on Monday, March 16, at 8:30 a.m. ET. To participate, please dial 250-8889 or 545-0001 and reference conference ID 89741044.
Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma
2015-01-23 18:05:55| Biotech - Topix.net
Progenics Pharmaceuticals, Inc., announced today that it has dosed the first subject in the resumed pivotal Phase 2 clinical study of Azedra in patients with malignant pheochromocytoma and paraganglioma. The trial is being conducted under a Special Protocol Assessment with the U.S. Food and Drug Administration .
Tags: trial
pharmaceuticals
pivotal
relaunches
Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc....
2013-09-01 21:36:22| Biotech - Topix.net
With August winding down, summer won't be around much longer. Several health-care stocks still had hot days this past week, though.
Tags: inc
pharmaceuticals
therapeutics
progenics